Help protect against typhoid fever
Before you travel, book an appointment and ask about VIVOTIF
Important safety information
VIVOTIF is an oral vaccine for protection of adults and children older than 5 years against typhoid fever, a disease caused by bacteria called Salmonella enterica serovar Typhi (abbr. S. typhi). The final dose of VIVOTIF should be taken at least 1 week before travelling to an area where there is risk of exposure to S. typhi. Immunization may not be suitable for everyone and can be associated with adverse events. 100% protection cannot be guaranteed. VIVOTIF is not indicated to treat the symptoms or reduce consequences of typhoid fever, including death. The vaccine should not replace standard preventive measures such as handwashing and avoiding potentially contaminated food and water.
The most commonly reported side effects of VIVOTIF during clinical studies were: stomach pain, feeling or being sick (nausea and vomiting), diarrhea, fever, flu-like symptoms, headache, and rash.
Side effects that have been reported very rarely during normal use include skin irritation, rashes, red or lumpy raised rashes, itching and hives, severe allergic reactions with drops of blood pressure and loss of consciousness, weakness, generally feeling unwell, shivering, tiredness, pins and needles, dizziness, and joint and muscle pain.
These symptoms disappear spontaneously within a few days. This is not a complete list of side effects. For any unexpected effects while taking VIVOTIF, contact your healthcare professional.
Learn more about VIVOTIF by consulting the Medication Information. Ask your healthcare professional if VIVOTIF is suitable for you.